Reck, M.Barlesi, F.Yang, , J. C.-H.Westeel, V.Felip, E.Ozguroglu, M.Dols, M. CoboSullivan, R.Kowalski, D.Andric, Z.Lee, D. H.Sezer, A.Shamrai, V.Szalai, Z.Wang, X.Xiong, H.Jacob, N.Mehr, K. TadjalliPark, K.2022-11-042022-11-0420221556-0864http://hdl.handle.net/11727/8005enginfo:eu-repo/semantics/closedAccessavelumabNSCLCfirst-lineAvelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+NSCLC: Primary Analysis from JAVELIN Lung 100conferenceObject1793939000858678100062